Insulet (PODD +2.7%), a maker of insulin infusion devices for diabetics, is trading higher...


Insulet (PODD +2.7%), a maker of insulin infusion devices for diabetics, is trading higher thanks to a bullish note from Barrington. While noting Insulet's recent Q4 report missed estimates, the firm still expects Insulet's OmniPod pump to act as a positive catalyst for shares.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs